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Introduction
Juvenile Dermatomyositis (JDM) is a rare life threatening
disease affecting children. Symptoms include severe
proximal muscle weakness and characteristic skin rashes.
Vascular pathology is often a key finding in JDM includ-
ing typical features of capillary drop out and abnormal
blood vessel endothelial cells. We have observed that
another common finding in JDM biopsies is the presence
of tubuloreticular inclusions (TRI) detected by electron
microscopy (EM) in blood vessel endothelial cells in mus-
cle and the overlying skin. These are tubule-like struc-
tures within cisternae of endoplasmic reticulum.
Objectives
The aim of this study was to determine the frequency and
specificity of TRIs in JDM biopsies compared to muscle
biopsies investigated for other pathologies
Methods
The UK JDM Biomarker and Cohort Study (JDBCS) pro-
vides access to a large JDM cohort, with linked samples
and biopsies, (n=446, biopsies n=135). We examined
pathology by EM of 41 JDM biopsies and recorded
reports of TRIs in blood vessel endothelial cells.
Results
Tubuloreticular inclusions were demonstrated in blood
vessel endothelial cells in 80% of JDM muscle biopsies
(33/41) and in the overlying clinically unaffected skin in
78% of cases (26/33) where this tissue was available. In
contrast no TRIs in vessel endothelial cells had previously
been reported in muscle biopsies investigated for other
pathologies in children (n>500).
Conclusion
The high number of JDM muscle biopsies with identified
TRIs compared to control biopsies investigated for other
diseases suggests that TRI’s are a specific marker of JDM
pathology. TRIs have also been found in other diseases
such as glomerulonephritis (GN), lupus nephritis (LN),
HIV and Degos disease and are suggested to be a biomar-
ker of type1 interferon (IFN) exposure. Type 1 IFN gene
and chemokine signature is thought to be associated with
JDM pathology and clinical features. The high specificity
of TRIs in vessel endothelium in JDM biopsies compared
to non-JDM biopsies suggests that their detection is use-
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